Top

Published in:

01-09-2008 | Review

The Epidemiology of Obesity and Gastrointestinal and Other Diseases: An Overview

Author: Paul Moayyedi

Published in: Digestive Diseases and Sciences | Issue 9/2008

Abstract

The worldwide prevalence of obesity continues to increase, with devastating implications for overall health. Epidemiological trends indicate the primary contributors are environmental (e.g., increased caloric intake, lack of exercise), although the evidence is surprisingly equivocal. Increased body mass index (BMI) is associated with an increase in all-cause mortality and in diseases related to this increasing mortality rate, such as diabetes mellitus, cardiovascular disease, and cancer, including those of the gastrointestinal system. Some of these associations are even more pronounced when obesity is measured by waist-to-hip ratio, a marker of visceral adipose tissue, versus BMI. Higher BMI is related to increased risk of developing gall stones, and obese patients experience GI symptoms, such as vomiting and diarrhea, more often compared with those of normal body mass. Although the exact cause remains uncertain, these symptoms may be connected to eating habits or to changes in gastrointestinal motility.

Data from National Health and Nutrition Examination Survey. Centres for Disease Control and Prevention, National Center for Health Statistics, Health, United States 2006

Wang Y, Mi J, Shan XY, Wang QJ, Ge KY (2007) Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes 31:177–188. doi:10.1038/sj.ijo.0803354 CrossRef

World Health Organization. Available at: http://www.who.int/ncd_surveillance/infobase/web/InfoBaseCommon/Images/bmioverweightmaps.gif. Accessed May 31 2007

Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J et al (2005) A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 352:1138–1145. doi:10.1056/NEJMsr043743 PubMedCrossRef

Lyon HN, Hirschhorn JN (2005) Genetics of common forms of obesity: a brief overview. Am J Clin Nutr 82(Suppl 1):215S–217SPubMed

Farooqi IS, Wangensteen T, Collins S, Kimber W, Matarese J, Keogh JM et al (2007) Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med 356:237–247. doi:10.1056/NEJMoa063988 PubMedCrossRef

Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak GJ, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295:1549–1555. doi:10.1001/jama.295.13.1549 PubMedCrossRef

Rodriguez Artalejo F, Lopez Garcia E, Gutierrez-Fisac JL, Banegas Banegas JR, Lafuente Urdinguio PJ, Dominguez Rojas V (2002) Changes in the prevalence of overweight and obesity and their risk factors in Spain, 1987–1997. Prev Med 34:72–81. doi:10.1006/pmed.2001.0962 PubMedCrossRef

Viner RM, Cole TJ (2006) Who changes body mass between adolescence and adulthood? Factors predicting change in BMI between 16 year and 30 years in the 1970 British Birth Cohort. Int J Obes 30:1368–1374. doi:10.1038/sj.ijo.0803183 CrossRef

10.

Ward H, Tarasuk V, Mendelson R (2007) Socioeconomic patterns of obesity in Canada: modeling the role of health behaviour. App Physiol Nutr Metab 2:206–216CrossRef

11.

Vieweg VR, Johnston CH, Lanier JO, Fernandez A, Pandurangi AK (2007) Correlation between high risk obesity groups and low socioeconomic status in school children. South Med J 100:8–13PubMed

12.

Fernald LC (2007) Socio-economic status and body mass index in low-income Mexican adults. Soc Sci Med 64:2030–2042. doi:10.1016/j.socscimed.2007.02.002 PubMedCrossRef

13.

Vanasse A, Demers M, Hemiari A, Courteau J (2006) Obesity in Canada: where and how many? Int J Obes 30:677–683. doi:10.1038/sj.ijo.0803168 CrossRef

14.

Janssen I, Boyce WF, Simpson K, Pickett W (2006) Influence of individual- and area-level measures of socioeconomic status on obesity, unhealthy eating, and physical inactivity in Canadian adolescents. Am J Clin Nutr 83:139–145PubMed

15.

Prentice AM, Jebb SA (1995) Obesity in Britain: gluttony or sloth? BMJ 311:437–439PubMed

16.

Kaplan MS, Huguet N, Newsom JT, McFarland BH, Lindsay J (2003) Prevalence and correlates of overweight and obesity among older adults: findings from the Canadian national population health survey. J Gerontol A Biol Sci Med Sci 58:1018–1030PubMed

17.

Harrison M, Burns CF, McGuinness M, Heslin J, Murphy NM (2006) Influence of a health education intervention on physical activity and screen time in primary school children: ‘switch off—get active’. J Sci Med Sport 9:388–394. doi:10.1016/j.jsams.2006.06.012 PubMedCrossRef

18.

Kant AK, Graubard BI (2006) Secular trends in patterns of self-reported food consumption of adult Americans: NHANES 1971–1975 to NHANES 1999–2002. Am J Clin Nutr 84:1215–1223PubMed

19.

Field AE, Austin SB, Gillman MW, Rosner B, Rockett HR, Colditz GA (2004) Snack food intake does not predict weight change among children and adolescents. Int J Obes Relat Metab Disord 28:1210–1216. doi:10.1038/sj.ijo.0802762 PubMedCrossRef

20.

Heini AF, Weinsier RL (1997) Divergent trends in obesity and fat intake patterns: the American paradox. Am J Med 102:259–264. doi:10.1016/S0002-9343(96)00456-1 PubMedCrossRef

21.

Keith SW, Redden DT, Katzmarzyk PT, Boggiano MM, Hanlon EC, Benca RM et al (2006) Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes 30:1585–1594. doi:10.1038/sj.ijo.0803326 CrossRef

22.

Hill JO, Wyatt HR, Reed GW, Peters JC (2003) Obesity and the environment: where do we go from here? Science 299:853–855. doi:10.1126/science.1079857 PubMedCrossRef

23.

Christakis NA, Fowler JH (2007) The spread of obesity in a large social network over 32 years. N Engl J Med 357:370–379. doi:10.1056/NEJMsa066082 PubMedCrossRef

24.

Egger G, Swinburn B (1997) An “ecological” approach to the obesity pandemic. BMJ 315:477–480PubMed

25.

Ogilvie D, Hamlet N (2005) Obesity: the elephant in the corner. BMJ 331:1545–1548. doi:10.1136/bmj.331.7531.1545 PubMedCrossRef

26.

Ellaway A, Macintyre S, Bonnefoy X (2005) Graffiti, greenery, and obesity in adults: secondary analysis of European cross sectional survey. BMJ 331:611–612. doi:10.1136/bmj.38575.664549.F7 PubMedCrossRef

27.

Bender R, Jockel KH, Trautner C, Spraul M, Berger M (1999) Effect of age on excess mortality in obesity. JAMA 281:1498–1504. doi:10.1001/jama.281.16.1498 PubMedCrossRef

28.

Flegal KM, Graubard BI, Williamson DF, Gail MH (2005) Excess deaths associated with underweight, overweight, and obesity. JAMA 293:1861–1867. doi:10.1001/jama.293.15.1861 PubMedCrossRef

29.

Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB (2003) Years of life lost due to obesity. JAMA 289:187–193. doi:10.1001/jama.289.2.187 PubMedCrossRef

30.

Ogden CL, Yanovski SZ, Carroll MD, Flegal KM (2007) The epidemiology of obesity. Gastroenterology 132:2087–2102. doi:10.1053/j.gastro.2007.03.052 PubMedCrossRef

31.

Park JH, Yoon SJ, Lee H, Jo HS, Lee SI, Kim Y et al (2006) Burden of disease attributable to obesity and overweight in Korea. Int J Obes 30:1661–1669. doi:10.1038/sj.ijo.0803321 CrossRef

32.

Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R et al (2006) Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 355:763–778. doi:10.1056/NEJMoa055643 PubMedCrossRef

33.

McGee DL (2005) Diverse populations collaboration. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 15:87–97. doi:10.1016/j.annepidem.2004.05.012 PubMedCrossRef

34.

Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E et al (2006) Body-mass index and mortality in Korean men and women. N Engl J Med 355:779–787. doi:10.1056/NEJMoa054017 PubMedCrossRef

35.

Gu D, He J, Duan X, Reynolds K, Wu X, Chen J et al (2006) Body weight and mortality among men and women in China. JAMA 295:776–783. doi:10.1001/jama.295.7.776 PubMedCrossRef

36.

Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr (1999) Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 341:1097–1105. doi:10.1056/NEJM199910073411501 PubMedCrossRef

37.

Must A, Spadano J, Coakley EH, Field AE, Colditz GA, Dietz WH (1999) The disease burden associated with overweight and obesity. JAMA 282:1523–1529. doi:10.1001/jama.282.16.1523 PubMedCrossRef

38.

Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH et al (2001) Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161:1581–1586. doi:10.1001/archinte.161.13.1581 PubMedCrossRef

39.

Cooper C, Inskip H, Croft P, Campbell L, Smith G, McLaren M et al (1998) Individual risk factors for hip osteoarthritis: obesity, hip injury, and physical activity. Am J Epidemiol 147:516–522PubMed

40.

Bray GA (1996) Health hazards of obesity. Endocrinol Metab Clin North Am 25:907–919. doi:10.1016/S0889-8529(05)70361-3 PubMedCrossRef

41.

Yan LL, Daviglus ML, Liu K, Stamler J, Wang R, Pirzada A et al (2006) Midlife body mass index and hospitalization and mortality in older age. JAMA 295:190–198. doi:10.1001/jama.295.2.190 PubMedCrossRef

42.

McMillan DC, Sattar N, Lean M, McArdle CS (2006) ABC of obesity: obesity and cancer. BMJ 333:1109–1111. doi:10.1136/bmj.39042.565035.BE1 PubMedCrossRef

43.

Bergström A, Pisani P, Tenet V, Wolk A, Adami HO (2001) Overweight as an avoidable cause of cancer in Europe. Int J Cancer 91:421–30. doi :10.1002/1097-0215(200002)9999:9999<::AID-IJC1053>3.0.CO;2-T

44.

Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638. doi:10.1056/NEJMoa021423 PubMedCrossRef

45.

Kolovou GD, Anagnostopoulou KK, Salpea KD, Mikhailidis DP (2007) The prevalence of metabolic syndrome in various populations. Am J Med Sci 333:362–371. doi:10.1097/MAJ.0b013e318065c3a1 PubMedCrossRef

46.

Giovannucci E (2003) Nutrition, insulin, insulin like growth factors and cancer. Horm Metab Res 35:694–704. doi:10.1055/s-2004-814147 PubMedCrossRef

47.

Stürmer T, Buring JE, Lee IM, Gaziano JM, Glynn RJ (2006) Metabolic abnormalities and risk for colorectal cancer in the physicians’ health study. Cancer Epidemiol Biomarkers Prev 15:2391–2397. doi:10.1158/1055-9965.EPI-06-0391 PubMedCrossRef

48.

Wei EK, Ma J, Pollak MN, Rifai N, Fuch CS, Hankinson SE et al (2006) C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women. Cancer Epidemiol Biomarkers Prev 15:750–755. doi:10.1158/1055-9965.EPI-05-0820 PubMedCrossRef

49.

Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911–919. doi:10.1016/j.jaci.2005.02.023 PubMedCrossRef

50.

Wei EK, Giovannucci E, Fuchs CS, Willet WC, Mantzoros CS (2005) Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 97:1688–1694PubMedCrossRef

51.

Kelesidis I, Kelesidis T, Mantzoros CS (2006) Adiponectin and cancer: a systematic review. Br J Cancer 94:1221–1225. doi:10.1038/sj.bjc.6603051 PubMedCrossRef

52.

Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P et al (2005) INTERHEART study investigators. Obesity and the risk of myocardial infarction in 27, 000 participants from 52 countries: a case-control study. Lancet 366:1640–1649. doi:10.1016/S0140-6736(05)67663-5 PubMedCrossRef

53.

Giovannucci E, Michaud D (2007) The role of obesity and related metabolic disturbances in cancers of the colon, prostate and pancreas. Gastroenterology 132:2208–2225. doi:10.1053/j.gastro.2007.03.050 PubMedCrossRef

54.

Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW et al (2004) Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350:2549–2557. doi:10.1056/NEJMoa033179 PubMedCrossRef

55.

Thörne A, Lönnqvist F, Apelman J, Hellers G, Arner P (2002) A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord 26:193–199. doi:10.1038/sj.ijo.0801871 PubMedCrossRef

56.

Folsom AR, Kushi LH, Anderson KE, Mink PJ, Olson JE, Hong CP et al (2000) Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa women’s health study. Arch Intern Med 160:2117–2128. doi:10.1001/archinte.160.14.2117 PubMedCrossRef

57.

Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL (2006) Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut 55:708–714. doi:10.1136/gut.2005.076133 PubMedCrossRef

58.

Syngal S, Coakley EH, Willett WC, Byers T, Williamson DF, Colditz GA (1999) Long-term weight patterns and risk for cholecystectomy in women. Ann Intern Med 130:471–477PubMed

59.

Martinez J, Johnson CD, Sanchez-Paya J, de Madaria E, Robles-Diaz G, Pérez-Mateo M (2006) Obesity is a definitive risk factor of severity and mortality in acute pancreatitis: an updated meta-analysis. Pancreatology 6:206–209. doi:10.1159/000092104 PubMedCrossRef

60.

Johnson CD, Toh SK, Campbell MJ (2004) Combination of APACHE-II score and an obesity score (APACHE-O) for the prediction of severe acute pancreatitis. Pancreatology 4:1–6. doi:10.1159/000077021 PubMedCrossRef

61.

Delgado-Aros S, Locke GR 3rd, Camilleri M, Talley NJ, Fett S, Zinsmeister AR et al (2004) Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol 99:1801–1806. doi:10.1111/j.1572-0241.2004.30887.x PubMedCrossRef

62.

Talley NJ, Howell S, Poulton R (2004) Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am J Gastroenterol 99:1807–1814. doi:10.1111/j.1572-0241.2004.30388.x PubMedCrossRef

63.

Levy RL, Linde JA, Feld KA, Crowell MD, Jeffery RW (2005) The association of gastrointestinal symptoms with weight, diet, and exercise in weight-loss program participants. Clin Gastroenterol Hepatol 3:992–996. doi:10.1016/S1542-3565(05)00696-8 PubMedCrossRef

64.

Talley NJ, Quan C, Jones MP, Horowitz M (2004) Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil 16:413–419. doi:10.1111/j.1365-2982.2004.00530.x PubMedCrossRef

65.

Shinomiya T, Fukunaga M, Akamizu T, Irako T, Yokode M, Kangawa K et al (2005) Plasma acylated ghrelin levels correlate with subjective symptoms of functional dyspepsia in female patients. Scand J Gastroenterol 40:648–653. doi:10.1080/00365520510015403 PubMedCrossRef

66.

Bercik P, Verdu EF, Collins SM (2005) Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am 34:235–245. doi:10.1016/j.gtc.2005.02.007 PubMedCrossRef

67.

John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA (2006) Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther 23:1511–1523. doi:10.1111/j.1365-2036.2006.02915.x PubMedCrossRef

68.

Ma L, Tataranni PA, Hanson RL, Infante AM, Kobes S, Bogardus C et al (2005) Variations in peptide YY and Y2 receptor genes are associated with severe obesity in Pima Indian men. Diabetes 54:1598–1602. doi:10.2337/diabetes.54.5.1598 PubMedCrossRef

69.

Wolford JK, Colligan PB, Gruber JD, Bogardus C (2003) Variants in the interleukin 6 receptor gene are associated with obesity in Pima Indians. Mol Genet Metab 80:338–343. doi:10.1016/j.ymgme.2003.07.003 PubMedCrossRef

70.

Schulz LO, Bennett PH, Ravussin E, Kidd JR, Kidd KK, Esparza J et al (2006) Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the U.S. Diabetes Care 29:1866–1871. doi:10.2337/dc06-0138 PubMedCrossRef

71.

Hill JO, Peters JC, Wyatt HR (2007) The role of public policy in treating the epidemic of global obesity. Clin Pharmacol Ther 81:772–775. doi:10.1038/sj.clpt.6100107 PubMedCrossRef

72.

Avenell A, Broom J, Brown TJ, Roobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM (2004) Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 8(21):iii-iv, 1–182

Title: The Epidemiology of Obesity and Gastrointestinal and Other Diseases: An Overview
Author: Paul Moayyedi
Publication date: 01-09-2008
Publisher: Springer US
Published in: Digestive Diseases and Sciences / Issue 9/2008
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-008-0410-z

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2008

Adherence, Internalization, and Persistence of Helicobacter pylori in Hepatocytes

Probiotics and Blueberry Attenuate the Severity of Dextran Sulfate Sodium (DSS)-Induced Colitis

Intravenous Injection of Micafungin Counteracts Candida Albicans-Induced Aggravation of Duodenal Ulcers Caused by Cysteamine in Rats

High Recurrence Rates of Helicobacter pylori Infection Can Be Related to False-Positive Histologies

Accuracy of Endoscopic Ultrasound in the Diagnosis of Distal and Celiac Axis Lymph Node Metastasis in Esophageal Cancer: A Meta-Analysis and Systematic Review

The Association Between Obesity and GERD: A Review of the Epidemiological Evidence

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage